Anika Therapeutics | ANIK - Loan Capital

Stock Price
14.47
Daily Change
0.11 0.77%
Monthly
38.34%
Yearly
-14.88%
Q1 Forecast
13.92

Anika Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Agenus USD 23.6M 448K Sep/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Enanta Pharmaceuticals USD 0 0 Dec/2024
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Insmed USD 540.96M 1.24M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intrexon USD 0 198.67M Jun/2024
J&J USD 39.44B 30M Dec/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
MacroGenics USD 70.26M 4K Sep/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Rigel Pharmaceuticals USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 15.72B 2.45B Dec/2025
Smith & Nephew USD 3.3B 22M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.55M 30K Sep/2024
Veracyte USD 0 0 Mar/2025
Xencor USD 76.48M 11.29M Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025